title: Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?
authors.forename: Aleksander
authors.initials: A
authors.lastname: Krag
authors.forename: Flemming
authors.initials: F
authors.lastname: Bendtsen
authors.forename: Søren
authors.initials: S
authors.lastname: Møller
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001201:Ascites / Q000188:drug therapy* / Q000401:mortality; D002302:Cardiac Output / Q000187:drug effects*; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000401:mortality; D011433:Propranolol / Q000009:adverse effects*
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol